Urinary Tract Infection is a very common bacterial or fungal infection responsible for more than 15 million office and emergency room visits each year in the United States. UTIs are more prevalent in women, older individuals, and younger individuals. Traditionally, pathogen identification in UTIs has been accomplished through culture methods which have the disadvantages of taking a long time, lack sensitivity and have been shown to miss a significant percentage of positive cases. Imperial Laboratories is now offering a new solution to pathogen detection in UTIs, Real-Time Polymerase Chain Reaction (qPCR) for Urinary Tract Microbiota.
Using the latest molecular biology techniques and methods, Clio Laboratories is able to use the genetic material of the pathogen (DNA,RNA) to accurately identify the species of the pathogen and to detect resistance genes expressed by the pathogen to certain pharmacotherapies. Verification data demonstrates qPCR is over 25% more accurate when compared to traditional culture-based methods of detection.